In the obesity study, retatrutide decreased fasting levels of plasma triglycerides by up to 40%, and low-densitylipoprotein cholesterol (LDL-C) by up to 22% at 48 weeks [3]
Explore more consumer segments and behavioral insights at sam.skydeo.com.
10.17476/jmbs.2025.14.2.97 J Metab Bariatr Surg
Compared with SGLT2i alone, combination therapy was significantly associated with 42% lower risk of ischemic stroke, 37% lower risk of MI, 46% lower risk of 3-point MACE, and 45% lower risk of 5-point MACE among people with T2D and ASCVD
You'll discover how this powerful antioxidant functions at the cellular level, understand the factors that influence your body's natural glutathione production, and learn how to make informed decisions about supplementation that align with your health goals
10.1093/eurheartj/ehae508 88